People's Daily Online, Beijing, November 27th The Capital Assistance Pharmaceutical Packaging Industry Upgrade and Development Seminar (hereinafter referred to as the seminar) was held in Beijing yesterday. Jiantou Investment Co., Ltd. (hereinafter referred to as “Jiantou Investment”), China Pharmaceutical Packaging Association and “Economic Information Daily” as the joint organizers of this seminar, with pharmaceutical packaging related regulatory departments, industry experts and representative enterprises, etc. How to fully understand the opportunities and challenges of innovation and development in the pharmaceutical packaging industry, how to help the industry to upgrade and develop through the power of capital, how to help the outstanding enterprises in the industry to "go global" and strengthen exchanges and cooperation with the international community, and conducted in-depth discussions. Ke Wei, Assistant President of China Jianyin Investment Co., Ltd., and Ji Wei, Vice President of China Pharmaceutical Packaging Association attended the seminar and delivered speeches.

Pharmaceutical packaging is called the "second life" of medicines and plays an important role in protecting the safety and effectiveness of medicines. With the increase in the medical expenses caused by the improvement of the living standards of our people and the aging of the population, the development of new drugs and the pace of reform of the medical security system, the pharmaceutical packaging industry will continue to maintain rapid development.

Ke Wei said that pharmaceutical packaging is closely related to the quality of medicines and the safety of medicines. It is a key component of the pharmaceutical industry system and an important industry related to the national economy and people's livelihood. As a state-owned comprehensive investment group, China Construction Investment Group has a mission to promote technological advancement, promote industrial upgrading, build a cultural power, upgrade service consumption, and help improve people's livelihood. Jiantou Investment is an important investment platform of China Construction Investment Group. It is committed to cultivating Chinese technology and Chinese brands, and boosting China's economic restructuring and industrial transformation and upgrading. Last month, China Construction Investment Corporation and Jiantou Investment completed a controlling acquisition of the SGD project based in Paris, France. We hope that through the acquisition and integration of SGD, we will give full play to its advantages in global brand, technology, products and global business layout, and feed back the domestic market, providing traction for the upgrading and development of China's pharmaceutical packaging industry, and promoting Chinese medicine. Safety quality contributes strength.

Ji Wei said that after nearly 30 years of rapid development, the pharmaceutical packaging industry has developed from fragmented and backward to a standardized concentration stage. There are more than 1,500 existing enterprises with an output value of about 60 billion. China's pharmaceutical packaging materials enterprises are mainly private. With the rapid development of the industry in recent years, the joint ventures and foreign-invested enterprises in the industry have gradually increased, and the product quality and product structure of private enterprises have also been greatly improved. However, if enterprises continue to upgrade and develop, they need to be assisted in capital and policy. Therefore, this meeting is very timely. Through the full exchanges between the government, capital, experts and enterprises, the capital market can understand the field of pharmaceutical packaging. The status quo, the characteristics of development, and the development bottlenecks in terms of policies and markets, and targeted investment.

Experts from the National Development and Reform Commission, the Ministry of Commerce, and the State Administration of Foreign Exchange also attended the seminar. They also participated in discussions on the current situation of Chinese enterprises' foreign investment, and the heads of China Pharmaceutical Packaging Association and Jiantou Investment. In-depth discussion and exchanges with the heads of enterprises such as Shandong Pharmaceutical Glass Co., Ltd. on the opportunities and challenges faced by the innovation and upgrading of the pharmaceutical packaging industry.

Degradable materials, pharmaceutical packaging, pharmaceutical plastic products, reduced advantages